###begin article-title 0
Activation of Wnt/beta-Catenin Signaling Increases Insulin Sensitivity through a Reciprocal Regulation of Wnt10b and SREBP-1c in Skeletal Muscle Cells
###end article-title 0
###begin p 1
Conceived and designed the experiments: MA ECV ALP IM IGD. Performed the experiments: MA MF ECV IM IGD. Analyzed the data: MA MF ECV ALP IM IGD. Contributed reagents/materials/analysis tools: MF ALP IGD. Wrote the paper: IGD.
###end p 1
###begin title 2
Background
###end title 2
###begin p 3
###xml 81 87 <span type="species:ncbi:9606">humans</span>
Intramyocellular lipid accumulation is strongly related to insulin resistance in humans, and we have shown that high glucose concentration induced de novo lipogenesis and insulin resistance in murin muscle cells. Alterations in Wnt signaling impact the balance between myogenic and adipogenic programs in myoblasts, partly due to the decrease of Wnt10b protein. As recent studies point towards a role for Wnt signaling in the pathogenesis of type 2 diabetes, we hypothesized that activation of Wnt signaling could play a crucial role in muscle insulin sensitivity.
###end p 3
###begin title 4
Methodology/Principal Findings
###end title 4
###begin p 5
Here we demonstrate that SREBP-1c and Wnt10b display inverse expression patterns during muscle ontogenesis and regeneration, as well as during satellite cells differentiation. The Wnt/beta-catenin pathway was reactivated in contracting myotubes using siRNA mediated SREBP-1 knockdown, Wnt10b over-expression or inhibition of GSK-3beta, whereas Wnt signaling was inhibited in myoblasts through silencing of Wnt10b. SREBP-1 knockdown was sufficient to induce Wnt10b protein expression in contracting myotubes and to activate the Wnt/beta-catenin pathway. Conversely, silencing Wnt10b in myoblasts induced SREBP-1c protein expression, suggesting a reciprocal regulation. Stimulation of the Wnt/beta-catenin pathway i) drastically decreased SREBP-1c protein and intramyocellular lipid deposition in myotubes; ii) increased basal glucose transport in both insulin-sensitive and insulin-resistant myotubes through a differential activation of Akt and AMPK pathways; iii) restored insulin sensitivity in insulin-resistant myotubes.
###end p 5
###begin title 6
Conclusions/Significance
###end title 6
###begin p 7
We conclude that activation of Wnt/beta-catenin signaling in skeletal muscle cells improved insulin sensitivity by i) decreasing intramyocellular lipid deposition through downregulation of SREBP-1c; ii) increasing insulin effects through a differential activation of the Akt/PKB and AMPK pathways; iii) inhibiting the MAPK pathway. A crosstalk between these pathways and Wnt/beta-catenin signaling in skeletal muscle opens the exciting possibility that organ-selective modulation of Wnt signaling might become an attractive therapeutic target in regenerative medicine and to treat obese and diabetic populations.
###end p 7
###begin title 8
Introduction
###end title 8
###begin p 9
###xml 251 254 251 254 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008509-Kanazawa1">[1]</xref>
###xml 448 451 442 445 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008509-Welters1">[2]</xref>
###xml 576 579 567 570 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008509-Anagnostou1">[3]</xref>
The first suggestion for a role of Wnt signaling in the pathogenesis of type 2 diabetes came from a study which reported a single nucleotide polymorphism locus in the Wnt5b gene that confered susceptibility to type 2 diabetes in a Japonese population [1]. More recently, variants of the transcription factor TCF7L2, a component of the Wnt/beta-catenin pathway, were shown to be involved in beta-cell dysfunction and the etiology of type 2 diabetes [2]. In addition, a link between cellular glucose sensing and the Wnt/beta-catenin pathway was recently reported in macrophages [3], indicating that this pathway could be inappropriately activated in diabetic hyperglycemic or obese subjects. These results strongly suggest that Wnt signaling could be involved in the regulation of glucose homeostasis in different organs, particularly in insulin-responsive tissues such as skeletal muscle.
###end p 9
###begin title 10
The Wnt/beta-Catenin Signaling Pathway
###end title 10
###begin p 11
###xml 334 337 319 322 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008509-Aberle1">[4]</xref>
###xml 695 698 671 674 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008509-Cossu1">[5]</xref>
###xml 700 703 676 679 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008509-Ridgeway1">[6]</xref>
###xml 850 853 826 829 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008509-Miller1">[7]</xref>
A central feature of the canonical Wnt/beta-catenin pathway is the regulation of cytosolic beta-catenin protein levels via a destruction complex containing glycogen synthase kinase-3beta (GSK-3beta), adenomatous polyposis coli (APC) and axin. In the absence of Wnt signals, beta-catenin is targeted for ubiquitin-mediated degradation [4]. Binding of Wnt ligands to a Frizzled/LRP receptor complex leads to the inactivation of GSK-3beta and accumulation of cytosolic beta-catenin. Then beta-catenin translocates into the nucleus where it binds to TCF/LEF transcription factors to activate transcription of Wnt-responsive genes involved in cell proliferation (cyclin D1, myf5) and differentiation [5], [6]. Wnt signaling also plays a key role in adult tissues homeostasis by determining differentiating cell fate and maintaining stem cell pluripotency [7].
###end p 11
###begin title 12
Shift in Lipid Metabolism and Muscle Insulin Resistance
###end title 12
###begin p 13
###xml 161 164 161 164 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008509-Unger1">[8]</xref>
###xml 288 291 288 291 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008509-Virkamaki1">[9]</xref>
###xml 293 297 293 297 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008509-Machann1">[10]</xref>
###xml 403 407 403 407 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008509-Shimomura1">[11]</xref>
###xml 409 413 409 413 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008509-Foretz1">[12]</xref>
###xml 415 419 415 419 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008509-Foretz2">[13]</xref>
###xml 466 470 466 470 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008509-Ducluzeau1">[14]</xref>
###xml 483 487 483 487 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008509-GuilletDeniau1">[15]</xref>
###xml 703 707 703 707 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008509-GuilletDeniau1">[15]</xref>
###xml 279 287 <span type="species:ncbi:9606">patients</span>
###xml 459 465 <span type="species:ncbi:9606">humans</span>
###xml 556 559 <span type="species:ncbi:10116">rat</span>
Several tissues, including skeletal muscle, display with ageing an adverse shift in lipid metabolism which contributes to insulin resistance and type 2 diabetes [8]. Insulin resistance has been linked to the accumulation of intramyocellular lipids in skeletal muscle of diabetic patients [9], [10] in relation with the lipogenic transcription factor SREBP-1c which mediates insulin's actions on hepatic [11], [12], [13] and skeletal muscle gene expression in humans [14] and rodents [15]. We have shown that adenoviral delivery of SREBP-1 gene to cultured rat muscle satellite cells resulted in a gene expression profile that would suppress fat oxidation and promote intramyocellular lipid accumulation [15], suggesting that SREBP-1c plays a role in the development and/or maintenance of skeletal muscle insulin resistance.
###end p 13
###begin title 14
Role of Wnt Signaling in the Balance Adipogenesis/Myogenesis
###end title 14
###begin p 15
###xml 184 188 184 188 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008509-TaylorJones1">[16]</xref>
###xml 253 257 253 257 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008509-Prestwich1">[17]</xref>
###xml 382 386 382 386 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008509-Sabourin1">[18]</xref>
###xml 579 583 575 579 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008509-Grimaldi1">[19]</xref>
###xml 585 589 581 585 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008509-Teboul1">[20]</xref>
###xml 621 625 617 621 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008509-Aguiari1">[21]</xref>
Down-regulation of Wnt signaling may alter myoblastic differentiation potential as a function of age, as it controls the balance between myogenic and adipogenic potential in myoblasts [16], suggesting that endogenous Wnt signaling inhibits adipogenesis [17]. Although myoblast determination and differentiation are regulated by myogenic transcription factors (myf5, myoD, myogenin) [18], their activity can be overcome in vitro so that myoblasts can be induced to transdifferentiate into adipocyte-like cells by treatment with thiazolidinediones, potent activators of PPAR-gamma [19], [20], or high glucose concentration [21]. These results strongly suggest that skeletal muscle satellite cells are able to enter an adipogenic program under particular pathophysiological conditions.
###end p 15
###begin p 16
###xml 169 173 169 173 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008509-GuilletDeniau1">[15]</xref>
We have shown previously that high glucose concentration up-regulated SREBP-1c in cultured muscle satellite cells, leading to de novo lipogenesis and insulin resistance [15]. Here we show a reciprocal regulation between SREBP-1c and Wnt10b mRNA and protein expression in muscle cells, in relation with intramyocellular lipid deposition and insulin resistance. Surprisingly, stimulation of the Wnt/beta-catenin pathway through SREBP-1c knockdown, GSK-3beta inhibition or Wnt10b over-expression prevented intramyocellular lipid synthesis, redirected myotubes toward a myogenic phenotype and restored insulin sensitivity in insulin-resistant myotubes through a molecular mechanism involving a differential activation of Akt/PKB and AMPK pathways.
###end p 16
###begin title 17
Results
###end title 17
###begin title 18
SREBP-1c and Wnt10b Proteins Show an Inverse Expression Pattern In Vivo
###end title 18
###begin p 19
###xml 0 9 0 9 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0008509-g001">Figure 1A</xref>
###xml 179 182 <span type="species:ncbi:10116">rat</span>
Figure 1A represents the evolution of SREBP-1c and Wnt proteins that are expressed during skeletal muscle ontogenesis. Wnt3 protein was strongly expressed in hind limb muscles of rat fetuses, but was rapidly down-regulated after birth, whereas Wnt5a and Wnt7 were not detected (result not shown). In contrast, Wnt10b protein was barely detectable in fetal muscles, but was strongly up-regulated after birth and remained elevated in newborn muscles throughout suckling. Then it decreased drastically after weaning to become quite undetectable in adult muscles. Conversely, SREBP-1c protein was not expressed in muscles from birth to weaning while Wnt10b protein level was elevated. After weaning, SREBP-1c precursor and mature forms increased by 5-fold when muscle growth was over, as shown by a strong expression of the fast Myosin Heavy Chain-2 protein (MyHC-2). These results suggest that Wnt10b protein could be only expressed in myoblasts that are involved in postnatal skeletal muscle growth, a period during which the lipogenic factor SREBP-1c is not detected.
###end p 19
###begin title 20
Differential expression of SREBP-1c and Wnt proteins during skeletal muscle ontogenesis and regeneration.
###end title 20
###begin p 21
###xml 1 2 1 2 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">A</bold>
###xml 240 241 240 241 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">B</bold>
(A) Western blot analysis showing inverse expression patterns between Wnt10b and SREBP-1c during ontogenesis. The developmental stages are underlined using antibodies against developmental (MyHC-Dev) and fast (MyHC-2) myosin heavy chains. (B) Western blot analysis of Wnt10b and SREBP-1c protein levels in regenerating (R) adult EDL muscles at 2, 8, and 30 days after crush injury as compared to contralateral control (C) EDL. The down-regulation of SREBP-1c was concomitant with the up-regulation of Wnt10b throughout regeneration. The blots are representative of 3 independent experiments.
###end p 21
###begin p 22
###xml 246 250 246 250 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008509-Bassaglia1">[22]</xref>
###xml 630 639 630 639 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0008509-g001">Figure 1B</xref>
To challenge this hypothesis, we assessed the differential expression of Wnt10b and SREBP-1c proteins during skeletal muscle regeneration in adult EDL muscles. EDL muscle from the left hind limb was crushed using tweezers as previously described [22] and the non-injured contralateral EDL was taken as a control. Two days after crush injury, Wnt10b protein levels increased dramatically and remained elevated until 8 days following the injury, then became undetectable after 30 days when regeneration was over. Myogenin was transiently up-regulated during the regeneration process, whereas SREBP-1c was completely down-regulated (Figure 1B). These findings suggest that Wnt10b might activate a signaling pathway that prevents the expression of lipogenic factors during skeletal muscle growth and regeneration.
###end p 22
###begin title 23
SREBP-1c and Wnt10b Show an Inverse Expression Pattern in Cultured Satellite Cells
###end title 23
###begin p 24
###xml 490 499 490 499 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0008509-g002">Figure 2A</xref>
###xml 749 758 749 758 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0008509-g002">Figure 2A</xref>
As muscle growth and regeneration occur through the activation of satellite cells, we studied the expression of Wnt10b protein in primary cultures of satellite cells isolated from hind limb muscles. Myoblasts were allowed to proliferate for 5 days, then fusion was induced and spontaneously contracting myotubes were obtained at day 9. Wnt10b protein was strongly expressed in proliferating myoblasts, then decreased during cell fusion and was no longer detectable in contracting myotubes (Figure 2A), whereas Wnt3 protein expression remained almost unchanged. In contrast, Wnt10b down-regulation was concomitant with the up-regulation of SREBP-1c and fatty acid synthase (FAS) proteins, showing that lipogenesis was active in contracting myotubes (Figure 2A). These results demonstrated that Wnt10b and SREBP-1c proteins adopted inverse expression patterns according to the differentiation stage of myogenic cells.
###end p 24
###begin title 25
Wnt10b and SREBP-1c are also inversely expressed in cultured satellite cells.
###end title 25
###begin p 26
###xml 1 2 1 2 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">A</bold>
###xml 290 291 290 291 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">B</bold>
###xml 617 637 613 633 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="sec" rid="s4">Material and Methods</xref>
###xml 640 641 636 637 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">C</bold>
###xml 1053 1054 1040 1041 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">D</bold>
###xml 575 580 <span type="species:ncbi:10090">mouse</span>
(A) Western blot analysis showing an inverse expression pattern between Wnt10b and SREBP-1c proteins according to the differentiation stage. In contrast, Wnt3 remained almost unchanged throughout differentiation. SREBP-1c induced the up-regulation of the lipogenic enzyme FAS in myotubes. (B) Wnt10b knockdown was sufficient to up-regulate SREBP-1c and PPARgamma mRNAs, whereas Wnt10b over-expression down-regulated their expression. RT-PCR was performed on myoblasts transfected with a scrambled siRNA (lane 1), a pool of 3 Wnt10b siRNAs (lane 2), or a plasmid encoding the mouse Wnt10 cDNA (lane 3) as described in Material and Methods. (C) SREBP-1 knockdown stimulated Wnt signaling in contracting myotubes. Myotubes were transfected with SREBP-1 siRNAs or a scrambled siRNA, then treated or not with 10 nM insulin for 24 hours. SREBP-1 knockdown was sufficient to induce Wnt10b protein expression in myotubes, particularly in the presence of insulin, and to activate the Wnt/beta-catenin pathway, as shown by GSK-3beta and beta-catenin activities. (D) Wnt10b knockdown induced SREBP-1c protein expression in myoblasts. Myoblasts were transfected with 30 pmoles or 60 pmoles of a pool of 3 Wnt10b siRNAs, or with a scrambled siRNA as a control. Silencing Wnt10b was sufficient to induce SREBP-1c protein expression in myoblasts through the inhibition of Wnt/beta-catenin signaling. The blots are representative of 3 independent experiments.
###end p 26
###begin title 27
Wnt10b Silencing Increases SREBP-1c mRNA Expression in Myoblasts
###end title 27
###begin p 28
###xml 521 530 521 530 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0008509-g002">Figure 2B</xref>
###xml 237 242 <span type="species:ncbi:10090">mouse</span>
To determine whether Wnt10b knockdown could induce SREBP-1c expression, myoblasts were transfected with a mix of 3 specific Wnt10b siRNAs or with a control scrambled siRNA. In parallel, myotubes were transfected with a vector containing mouse Wnt10b cDNA. Total RNA was extracted 48 hours after transfection and semi-quantitative PCR was performed. Wnt10b knockdown was sufficient to induce SREBP-1c mRNA expression in myoblasts, whereas Wnt10b over-expression drastically decreased SREBP-1c mRNA expression in myotubes (Figure 2B). Furthermore, Wnt10b knockdown increased by 3-fold PPAR-gamma mRNA expression in myoblasts, whereas Wnt10b over-expression decreased PPAR-gamma mRNA in myotubes. In contrast, PPAR-beta and MyHC-2 mRNAs were unaffected. These results show that Wnt10b decreased SREBP-1c and PPAR-gamma expression at the transcriptional level.
###end p 28
###begin title 29
SREBP-1c Silencing Activates the Wnt/beta-Catenin Pathway in Contracting Myotubes
###end title 29
###begin p 30
###xml 632 641 632 641 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0008509-g002">Figure 2C</xref>
###xml 818 822 809 813 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Y216</sup>
###xml 940 944 928 932 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008509-Bhat1">[23]</xref>
###xml 1272 1281 1248 1257 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0008509-g002">Figure 2C</xref>
In order to determine whether SREBP-1c could inhibit Wnt10b expression, myotubes were transfected with a SREBP-1 siRNA duplex or with a control scrambled siRNA, and total proteins were extracted 48 hours later. SREBP-1c protein was hardly detectable in siRNA-transfected myotubes as compared with control myotubes, indicating a knockdown efficiency of more than 90%. Gene silencing was successful even in the presence of 10 nM insulin, a potent activator of SREBP-1c transcription. Surprisingly, SREBP-1c knockdown was sufficient to induce Wnt10b protein expression in contracting myotubes, particularly in the presence of insulin (Figure 2C). To determine whether SREBP-1c knockdown stimulated Wnt/beta-catenin signaling, the activity of GSK-3beta was checked using an antibody raised against phosphorylated GSK-3betaY216 which is active when phosphorylated, but is inactive when dephosphorylated in response to Wnt/beta-catenin signaling [23]. GSK-3beta activity decreased by 3-fold in SREBP-1c knocked-down myotubes. Furthermore, the dephosphorylated active form of beta-catenin was increased in these cells, while total GSK-3beta and total beta-catenin remained unchanged. MyHC-2 level showed that myotubes remained terminally differentiated after SREBP-1c knockdown (Figure 2C). Taken together, these results suggest that SREBP-1c could be involved in the down-regulation of Wnt signaling which is observed in contracting myotubes.
###end p 30
###begin title 31
Wnt10b Silencing Induces SREBP-1c Protein Expression in Myoblasts
###end title 31
###begin p 32
###xml 412 416 409 413 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Y216</sup>
###xml 564 573 555 564 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0008509-g002">Figure 2D</xref>
We wanted to determine whether Wnt10b knockdown could conversely induce the expression of SREBP-1c protein in myoblasts. Total protein was extracted 48 hours after transfection of myoblasts with a mix of 3 specific Wnt10b siRNAs or with a control scrambled siRNA. Wnt10b knockdown was sufficient to induce 24 hours later SREBP-1c protein expression in myoblasts. The concomitant 2 to 3-fold increase in GSK-3betaY216 phosphorylation led to the down-regulation of active beta-catenin in transfected myoblasts, showing an inhibition of the Wnt/beta-catenin pathway (Figure 2D).
###end p 32
###begin title 33
Forced-Expression of Wnt10b Down-Regulates SREBP-1c in Contracting Myotubes
###end title 33
###begin p 34
###xml 424 433 424 433 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0008509-g003">Figure 3A</xref>
###xml 523 526 520 523 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">216</sup>
###xml 166 171 <span type="species:ncbi:10090">mouse</span>
In order to determine whether the over-expression of Wnt10b could be sufficient to down-regulate SREBP-1c in myotubes, cells were transfected with a plasmid encoding mouse Wnt10b cDNA, and cytosolic and nuclear proteins were extracted 48 hours later. Wnt10b over-expression was sufficient to totally abrogate the expression of the cytoplasmic-precursor and nuclear-active forms of SREBP-1c, even in the presence of insulin (Figure 3A). As expected, Wnt10b over-expression decreased GSK-3beta activity by dephosphorylating Y216 and induced the nuclear translocation of active beta-catenin, which led to the up-regulation of MyoD in the nucleus. These results demonstrate that the reactivation of the Wnt/beta-catenin pathway down-regulated the lipogenic factor SREBP-1c, but also stimulated the myogenic pathway in contracting myotubes. Altogether, our data suggest that the reciprocal regulation between SREBP-1c and Wnt10b resulted from a crosstalk between Wnt/beta-catenin signaling and the transcription factor SREBP-1c.
###end p 34
###begin title 35
Activation of Wnt signaling in contracting myotubes.
###end title 35
###begin p 36
###xml 1 2 1 2 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">A</bold>
###xml 623 624 617 618 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">B</bold>
###xml 122 127 <span type="species:ncbi:10090">mouse</span>
(A) Over-expression of Wnt10b cDNA down-regulated SREBP-1c protein. Myotubes were transfected with a plasmid encoding the mouse Wnt10b cDNA, then treated or not with 10 nM insulin for 24 hours. Western blot analysis of cytoplasmic (left panel) and nuclear (right panel) protein extracts showing the down-regulation of precursor and mature forms of SREBP-1c following the activation of the Wnt/beta-catenin pathway. Wnt10b over-expression induced the nuclear accumulation of active beta-catenin and MyoD. Blots were normalized using antibodies raised against the cytoplasmic protein GAPDH or the nuclear protein Lamin A/C. (B) Myotubes were submitted to a 48 hour-treatment with 1 microM BIO, then 10 nM insulin was added for 24 hours. BIO-mediated activation of the Wnt/beta-catenin pathway induced SREBP-1c down-regulation, even in the presence of insulin.
###end p 36
###begin title 37
Activation of the Wnt/beta-Catenin Pathway Down-Regulates SREBP-1c in Myotubes
###end title 37
###begin p 38
###xml 157 161 154 158 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008509-Sato1">[24]</xref>
###xml 211 214 205 208 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">216</sup>
###xml 232 241 226 235 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0008509-g003">Figure 3B</xref>
###xml 266 267 260 261 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">9</sup>
Myotubes were treated for 48 hours with 6-BromoIndirubin-3'-Oxime (BIO), a selective inhibitor of GSK-3 activity that activates the Wnt/beta-catenin pathway [24]. BIO decreased GSK-3beta activity by preventing Y216 phosphorylation (Figure 3B), but had no effect on S9 phosphorylation. As expected, the inhibition of GSK-3beta up-regulated the active form of beta-catenin, resulting in SREBP-1c down-regulation. These results show that reactivation of the Wnt/beta-catenin pathway whatever the technique used (SREBP-1c knockdown, Wnt10b over-expression or selective GSK-3beta inhibition) drastically diminished the lipogenic factor SREBP-1c in contracting myotubes.
###end p 38
###begin title 39
BIO Abolishes Glucose-Induced Intramyocellular Lipid Accumulation in Myotubes
###end title 39
###begin p 40
###xml 130 139 130 139 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0008509-g004">Figure 4A</xref>
###xml 246 255 246 255 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0008509-g004">Figure 4B</xref>
###xml 302 306 302 306 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008509-GuilletDeniau2">[25]</xref>
###xml 401 410 397 406 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0008509-g004">Figure 4C</xref>
###xml 601 610 597 606 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0008509-g004">Figure 4F</xref>
In myotubes cultured under physiological glucose concentration (5 mM), few lipid droplets were detected using Oil Red O staining (Figure 4A), whereas high glucose concentration (25 mM) drastically increased SREBP-1c-mediated de novo lipogenesis (Figure 4B), confirming what we have previously reported [25]. In contrast, no intramyocellular lipids were detected in myotubes treated with 1 microM BIO (Figure 4C). In addition, BIO was able to induce the formation of terminally-differentiated contracting myotubes, as the contractile apparatus was visible and nuclei appeared in a peripheral position (Figure 4F). Thus, activation of Wnt/beta-catenin signaling redirected muscle cells toward the myogenic pathway.
###end p 40
###begin title 41
Effect of BIO on intramyocellular lipid accumulation.
###end title 41
###begin p 42
###xml 84 85 84 85 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">A</bold>
###xml 102 103 102 103 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">B</bold>
###xml 166 167 162 163 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">C</bold>
###xml 249 250 245 246 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">D</bold>
###xml 286 287 282 283 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">E</bold>
###xml 302 303 298 299 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">F</bold>
Oil red O staining of intramyocellular lipids in myotubes cultured in 5 mM glucose (A) 25 mM glucose (B) or 25 mM glucose in the presence of 1 microM BIO for 5 days (C). Phase-contrast microphotographs of the same myotubes cultured in 5 mM glucose (D), or 25 mM glucose in the absence (E) or presence (F) of BIO. BIO totally abolished intramyocellular lipid deposition. Scale bar 20 microm.
###end p 42
###begin title 43
Effect of Wnt Signaling on 2-Deoxyglucose Transport in Contracting Myotubes
###end title 43
###begin p 44
###xml 71 72 71 72 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">3</sup>
###xml 538 559 538 559 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0008509-g005">Figure 5A, left panel</xref>
###xml 892 914 892 914 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0008509-g005">Figure 5A, right panel</xref>
As glucose transport reflects insulin sensitivity in skeletal muscle, H3-2-Deoxyglucose (2-DG) uptake was measured in contracting myotubes. Myotubes cultured under physiological glucose concentration (G5) showed high insulin sensitivity, as 10 nM insulin induced within 30 minutes a 2-fold increase in 2-deoxyglucose uptake. Surprisingly, BIO treatment or Wnt10b over-expression increased basal 2-deoxyglucose uptake by 30% and 40% respectively, whereas uptake in the presence of BIO and insulin was similar to insulin-stimulated uptake (Figure 5A, left panel). In contrast, myotubes cultured for 48 hours in high glucose concentration (G25) presented a drastic insulin-resistance, as insulin was unable to stimulate 2-deoxyglucose uptake. However, BIO or Wnt10b over-expression increased basal glucose uptake by 20% and 40%, respectively, and restored insulin sensitivity in these myotubes (Figure 5A, right panel). Thus, the activation of Wnt signaling had no effect on insulin-stimulated glucose uptake in insulin-sensitive conditions, but increased glucose transport independent of insulin and restored insulin sensitivity in insulin-resistant myotubes.
###end p 44
###begin title 45
Effect of Wnt signaling on glucose transport in contracting myotubes.
###end title 45
###begin p 46
###xml 1 2 1 2 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">A</bold>
###xml 276 296 272 292 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="sec" rid="s4">Material and Methods</xref>
###xml 511 512 505 506 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">B</bold>
###xml 920 921 910 911 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">C</bold>
###xml 106 111 <span type="species:ncbi:10090">mouse</span>
(A) Myotubes cultured in 5 mM glucose (G5) or in 25 mM glucose (G25) for 48 hours were transfected with a mouse Wnt10b cDNA or treated with 1 microM BIO. 2-deoxyglucose (2-DG) uptake was then measured in the presence or absence of 10 nM insulin for 30 minutes as described in Material and Methods. Data are expressed as mean+/-SE from 5 independent experiments performed in triplicate. Significant difference from G5, (***) p<0.0001; (**) p<0.02; Significant difference from G25, (###) p<0.0001; (##) p<0.001. (B) BIO induced GLUT4 translocation to the plasma membrane. Myotubes were cultured in 5 mM (G5) or 25 mM glucose (G25) for 48 hours in the presence or absence of 1 microM BIO. Myotubes were treated or not with 10 nM insulin for 30 minutes, then plasma membranes were isolated. Western blot analysis showed that insulin and BIO induced GLUT4 translocation to the plasma membrane, whereas GLUT1 was unaffected. (C) Quantification of GLUT4 and GLUT1 translocation. Data are expressed as mean+/-SE from 4 independent experiments. Significant difference from G5, (***) p<0.0001; (**) p<0.01; (*) p<0.05.
###end p 46
###begin title 47
BIO Induces GLUT4 Translocation
###end title 47
###begin p 48
###xml 211 220 211 220 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0008509-g005">Figure 5B</xref>
###xml 547 556 547 556 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0008509-g005">Figure 5B</xref>
###xml 558 567 558 567 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0008509-g005">Figure 5C</xref>
In skeletal muscle, glucose transport is carried out by the insulin-sensitive glucose transporter GLUT4. In myotubes cultured in G5, insulin induced GLUT4 translocation to the plasma membrane within 30 minutes (Figure 5B). In contrast, insulin did not induce GLUT4 translocation in myotubes cultured in G25, confirming a strong insulin resistance. Surprisingly, BIO per se induced GLUT4 translocation to the plasma membrane in G25-cultured myotubes, and insulin had an additive effect. This effect was specific for GLUT4, as GLUT1 was unaffected (Figure 5B, Figure 5C). This experiments showed that activation of Wnt/beta-catenin signaling induced GLUT4 translocation to the plasma membrane through an insulin independent pathway.
###end p 48
###begin title 49
Effect of BIO on GSK-3beta Activity
###end title 49
###begin p 50
###xml 210 213 207 210 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">216</sup>
###xml 447 449 441 443 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">S9</sup>
###xml 467 476 461 470 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0008509-g006">Figure 6A</xref>
In order to decipher the signaling pathways involved in BIO effects, we performed time-course experiments in myotubes cultured in G5 or G25. Within 30 minutes, BIO decreased GSK-3beta activity, as assessed by Y216 phosphorylation, and maximal inhibition (70% and 60% in myotubes cultured in G5 and G25 respectively) was observed after about 4 hours, then remained for 12 hours in both cases. In contrast, BIO had no significant effect on GSK-3betaS9 phosphorylation (Figure 6A).
###end p 50
###begin title 51
Time-course of BIO effects on GSK-3beta activity, Akt, AMPK and MAPK signaling in contracting myotubes.
###end title 51
###begin p 52
###xml 226 227 222 223 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">A</bold>
###xml 270 274 263 267 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Y216</sup>
###xml 363 365 353 355 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">S9</sup>
###xml 384 385 374 375 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">B</bold>
###xml 403 407 393 397 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">S241</sup>
###xml 413 417 403 407 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">T308</sup>
###xml 427 431 417 421 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">S588</sup>
###xml 475 479 465 469 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">S473</sup>
###xml 539 540 529 530 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">C</bold>
###xml 567 571 553 557 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">S485</sup>
###xml 620 624 602 606 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">T172</sup>
###xml 762 766 740 744 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">S485</sup>
###xml 936 937 914 915 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">D</bold>
Myotubes were cultured in 5 mM (G5) or 25 mM (G25) glucose concentration for 48 hours, then 1 microM BIO was added. Upper panels show western blots whereas lower panels show quantifications of 3 to 5 independent experiments. (A) BIO decreased within 30 minutes GSK-3betaY216 phosphorylation in myotubes cultured either in G5 or G25, but had no effect on GSK-3betaS9 phosphorylation. (B) BIO induced PDK1S241, Akt1T308 and AS160S588 phosphorylations, but had no effect on Akt2S473 phosphorylation in myotubes cultured either in G5 or G25. (C) BIO increased AMPK-alpha1S485 phosphorylation, but had no effect on AMPK-alphaT172 phosphorylation in myotubes cultured in G5 (left panels). In contrast, BIO had a biphasic effect in myotubes cultured in G25: AMPK-alpha1S485 phosphorylation was decreased to a basal level within 30 minutes, then increased with a time-course similar to that observed in myotubes cultured in G5 (right panels). (D) BIO decreased Erk1/2 phosphorylation with a similar time-course in myotubes cultured either in G5 or G25. Data are expressed as mean+/-SE from 3 independent experiments.
###end p 52
###begin title 53
Effect of BIO on Akt Signaling
###end title 53
###begin p 54
###xml 172 175 172 175 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">308</sup>
###xml 222 226 222 226 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008509-Alessi1">[26]</xref>
###xml 288 291 288 291 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">473</sup>
###xml 300 304 300 304 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008509-Sarbassov1">[27]</xref>
###xml 370 374 370 374 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">S241</sup>
###xml 432 436 432 436 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">T308</sup>
###xml 491 495 491 495 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">S473</sup>
###xml 629 632 629 632 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">588</sup>
###xml 656 677 656 677 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0008509-g006">Figure 6B, left panel</xref>
###xml 697 701 697 701 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">T308</sup>
###xml 711 715 711 715 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">S588</sup>
###xml 920 924 920 924 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">T308</sup>
###xml 934 938 934 938 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">S588</sup>
###xml 1013 1035 1013 1035 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0008509-g006">Figure 6B, right panel</xref>
Akt/PKB is a protein kinase activated by insulin and various growth factors through pathways involving PI3 kinase. Akt1 is activated by activation-loop phosphorylation at T308 by the pyruvate dehydrogenase kinase 1 (PDK1) [26], and Akt2 by phosphorylation within the carboxy terminus at S473 by mTor [27]. Our data show in myotubes cultured in G5 that BIO increased PDK1S241 autophosphorylation within 30 minutes, which induced Akt1T308 phosphorylation for 8 hours, but had no effect on Akt2S473 phosphorylation. Finally the Akt substrate AS160 (a Rab-GAPase involved in GLUT4 translocation) was activated by phosphorylation on S588 for at least 24 hours (Figure 6B, left panel). In contrast, Akt1T308 and AS160S588 were already highly phosphorylated in myotubes cultured in G25. Surprisingly, the first effect of BIO was to bring the phosphorylation state back to a basal level within 30 min. Then BIO up-regulated Akt1T308 and AS160S588 phosphorylations that remained elevated until 8 hours after BIO addition (Figure 6B, right panel). These results could explain how BIO induced GLUT4 translocation and increased glucose uptake in myotubes that were either sensitive or resistant to insulin action.
###end p 54
###begin title 55
Effect of BIO on AMP Kinase Signaling
###end title 55
###begin p 56
###xml 149 153 149 153 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008509-Kahn1">[28]</xref>
###xml 178 182 178 182 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008509-Jensen1">[29]</xref>
###xml 365 374 357 366 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0008509-g006">Figure 6C</xref>
###xml 445 448 433 436 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">485</sup>
###xml 472 475 460 463 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">172</sup>
###xml 560 564 544 548 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">S485</sup>
###xml 674 678 654 658 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">S485</sup>
###xml 747 751 723 727 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">S485</sup>
###xml 854 863 830 839 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0008509-g006">Figure 6C</xref>
###xml 342 347 <span type="species:ncbi:10090">mouse</span>
AMPK promotes GLUT4 translocation and glucose uptake in skeletal muscle by a signaling cascade independent of the classical insulin-PI3K-Akt pathway [28]. Recently, Jensen et al [29] showed that twitch-contraction stimulated glucose uptake through the activation of AMPK-alpha1 (but not AMPK-alpha2) independently of AS160 phosphorylation in mouse skeletal muscle. Figure 6C shows that BIO induced rapidly the phosphorylation of AMPK-alpha1 on S485, but had no effect on T172 phosphorylation in myotubes cultured in G5. In myotubes cultured in G25, AMPK-alpha1S485 phosphorylation was 3-fold higher than in myotubes cultured in G5. Addition of BIO down-regulated AMPK-alpha1S485 phosphorylation to a basal level within 30 minutes, then AMPK-alpha1S485 was phosphorylated according to a time-course similar to the one observed in myotubes cultured in G5 (Figure 6C).
###end p 56
###begin title 57
Effect of BIO on MAP Kinase Signaling
###end title 57
###begin p 58
###xml 153 157 150 154 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008509-Meijer1">[30]</xref>
###xml 197 206 194 203 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0008509-g006">Figure 6D</xref>
As the MAP kinase (MAPK) pathway is involved in insulin signal transduction, we wonder whether BIO, which was designed as a specific GSK-3beta inhibitor [30], could indirectly affect this pathway. Figure 6D shows that the rapid (30 minutes) inhibition of GSK-3beta inhibited Erk1/2 phosphorylation after 1 hour, this effect remaining for almost 12 hours in myotubes cultured in G5 or G25. Taken together these results show that BIO induced, as a downstream consequence of GSK-3beta inactivation, the inhibition of the MAP kinase pathway and the activation of Akt/PKB and AMPK pathways in skeletal muscle cells.
###end p 58
###begin title 59
Comparison between Insulin and BIO Signaling in Contracting Myotubes
###end title 59
###begin title 60
GSK-3beta activity
###end title 60
###begin p 61
###xml 319 320 312 313 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">9</sup>
###xml 359 362 352 355 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">216</sup>
###xml 364 373 357 366 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0008509-g007">Figure 7A</xref>
Myotubes cultured either in G5 or G25 were treated for 30 minutes with 10 nM insulin, and for 30 minutes or 1 hour with 1 microM BIO. Quantifications of western-blots show that GSK-3beta activity was inhibited in myotubes cultured in low or high glucose concentration through either insulin-induced phosphorylation of S9, or BIO-induced dephosphorylation of Y216 (Figure 7A).
###end p 61
###begin title 62
Comparison between insulin and BIO effects on intracellular signaling.
###end title 62
###begin p 63
###xml 169 170 165 166 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">A</bold>
###xml 199 201 192 194 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">S9</sup>
###xml 316 320 306 310 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Y216</sup>
###xml 370 371 360 361 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">B</bold>
###xml 395 399 385 389 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">S473</sup>
###xml 522 526 512 516 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">T308</sup>
###xml 627 628 617 618 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">C</bold>
###xml 656 660 642 646 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">S485</sup>
###xml 680 684 662 666 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">T172</sup>
###xml 793 794 775 776 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">D</bold>
###xml 848 852 830 834 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">S588</sup>
###xml 929 930 911 912 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">E</bold>
Myotubes cultured in 5 mM glucose (G5) or 25 mM glucose (G25) concentration were treated with 10 nM insulin for 30 minutes, or with 1 microM BIO for 30 and 60 minutes. (A) Insulin increased GSK-3betaS9 phosphorylation in myotubes cultured in G5 or G25, whereas BIO had no effect. In contrast, BIO decreased GSK-3betaY216 phosphorylation, whereas insulin had no effect. (B) Insulin increased Akt2S473 phosphorylation in myotubes cultured in G5, whereas myotubes cultured in G25 were resistant to insulin. BIO increased Akt1T308 phosphorylation in myotubes cultured in G5, and had a biphasic effect in myotubes cultured in G25. (C) BIO stimulated AMPK-alpha1S485 but not AMPK-alpha2T172 phosphorylation whatever the glucose concentration, whereas insulin had no effect on AMPK phosphorylation. (D) In contrast to BIO, insulin failed to increase AS160S588 phosphorylation. BIO showed a biphasic effect in myotubes cultured in G25. (E) Insulin increased Erk1/2 phosphorylation only in myotubes cultured in G5, whereas BIO diminished Erk1/2 phosphorylation in myotubes whatever the glucose concentration. Lower panels show quantifications of 3 independent experiments. Data are expressed as mean+/-SE. Significant difference between BIO and insulin, (###) p<0.001; (##) p<0.01. Significant difference between control and insulin (***) p<0.001; (**) p<0.01. NS: non significant.
###end p 63
###begin title 64
Akt signaling
###end title 64
###begin p 65
###xml 29 33 29 33 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">S473</sup>
###xml 69 73 69 73 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">T308</sup>
###xml 91 100 91 100 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0008509-g007">Figure 7B</xref>
###xml 119 123 119 123 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">S588</sup>
###xml 163 172 163 172 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0008509-g007">Figure 7D</xref>
###xml 218 222 218 222 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">S473</sup>
###xml 332 336 332 336 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">T308</sup>
###xml 346 350 346 350 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">S588</sup>
###xml 439 453 439 453 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0008509-g007">Figures 7B, 7D</xref>
While insulin stimulated Akt2S473 phosphorylation, BIO increased Akt1T308 phosphorylation (Figure 7B), leading to AS160S588 activation in myotubes cultured in G5 (Figure 7D). In contrast, insulin did not stimulate Akt2S473 phosphorylation in myotubes cultured in G25, whereas BIO induced a biphasic response: it first decreased Akt1T308 and AS160S588 phosphorylations to a basal level within 30 min, then reinduced these phosphorylations (Figures 7B, 7D). These results show that BIO is able to activate the Akt pathway in insulin-resistant myotubes through a way different from the classical insulin/PI3K pathway.
###end p 65
###begin title 66
AMPK signaling
###end title 66
###begin p 67
###xml 118 122 114 118 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">S485</sup>
###xml 206 210 198 202 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">T172</sup>
###xml 283 287 271 275 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">S485</sup>
###xml 305 314 293 302 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0008509-g007">Figure 7C</xref>
Insulin had no effect on AMPK signaling in myotubes cultured either in G5 or G25. In contrast, BIO induced AMPK-alpha1S485 phosphorylation whatever the glucose concentration, but had no effect on AMPK-alphaT172 phosphorylation. Thus, BIO stimulated AMPK signaling through AMPK-alpha1S485 phosphorylation (Figure 7C).
###end p 67
###begin title 68
MAPK signaling
###end title 68
###begin p 69
###xml 266 275 266 275 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0008509-g007">Figure 7D</xref>
BIO and insulin had opposite effects on MAPK signaling. BIO induced Erk1/2 dephosphorylation within 1 hour in myotubes cultured in G5 or G25, whereas insulin increased Erk1/2 phosphorylation in myotubes cultured in G5, but had no effect in myotubes cultured in G25 (Figure 7D).
###end p 69
###begin p 70
Taken together our results show that activation of the Wnt/beta-catenin pathway prevented an adipogenic phenotype and improved insulin sensitivity in skeletal muscle cells through a differential stimulation of the Akt and MAPK pathways.
###end p 70
###begin title 71
Discussion
###end title 71
###begin p 72
###xml 120 124 120 124 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008509-GuilletDeniau2">[25]</xref>
###xml 175 178 175 178 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008509-Cossu1">[5]</xref>
###xml 180 184 180 184 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008509-Takata1">[31]</xref>
###xml 224 228 224 228 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008509-Ross1">[32]</xref>
###xml 230 234 230 234 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008509-Bennett1">[33]</xref>
Our previous work demonstrated that high glucose concentration up-regulated SREBP-1c and insulin resistance in myotubes [25]. As Wnt proteins are known to initiate myogenesis [5], [31] and inhibit adipogenic differentiation [32], [33], we hypothesized that Wnt10b normally represses the expression of lipogenic genes such as SREBP-1c in skeletal muscle.
###end p 72
###begin title 73
Wnt/beta-Catenin Signaling Overcomes an Adipogenic Program in Muscle
###end title 73
###begin p 74
###xml 111 121 111 121 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0008509-g001">Figures 1A</xref>
###xml 123 125 123 125 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0008509-g002">2A</xref>
###xml 198 202 198 202 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008509-Bizeau1">[34]</xref>
###xml 535 544 535 544 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0008509-g001">Figure 1B</xref>
###xml 656 657 656 657 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;</sup>
###xml 658 659 658 659 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;</sup>
###xml 770 774 770 774 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008509-Vertino1">[35]</xref>
###xml 105 109 <span type="species:ncbi:10116">rats</span>
###xml 293 298 <span type="species:ncbi:10090">mouse</span>
###xml 660 664 <span type="species:ncbi:10090">mice</span>
Here we show that Wnt10b was detected as long as SREBP-1c was not present in growing muscles of suckling rats (Figures 1A, 2A). As SREBP-1c is sensitive to the nutritional status in skeletal muscle [34], we cannot rule out a role for poly-unsaturated fatty acids (PUFAs) which are abundant in mouse milk. Conversely, a strong expression of SREBP-1c in adult muscle was concomitant with the loss of Wnt10b. On the contrary, the regeneration process reinduced Wnt10b protein expression and totally down-regulated SREBP-1c in EDL muscle (Figure 1B). This is supported by the observation that muscle regeneration was impaired in the Tibialis Anterior of Wnt10b-/- mice, where excessive lipid accumulation occurred within activated satellite cells and regenerating myofibers [35]. Thus, upon satellite cells activation, which started the myogenic program, the lipogenic protein SREBP-1c remained absent. These findings were confirmed in vitro as, whatever the technique used (SREBP-1 knockdown, Wnt10b over-expression or GSK-3beta inbibition through BIO), activation of the Wnt/beta-catenin pathway decreased SREBP-1c mRNA and protein levels in contracting myotubes. Conversely, silencing Wnt10b was sufficient to increase SREBP-1c mRNA and protein as well as the adipogenic phenotype of myoblasts, as shown by the up-regulation of PPAR-gamma mRNAs.
###end p 74
###begin p 75
###xml 562 566 562 566 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008509-Simoneau1">[36]</xref>
###xml 613 617 613 617 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008509-Takata1">[31]</xref>
###xml 749 754 <span type="species:ncbi:10090">mouse</span>
These results suggest that activation of Wnt signaling overcame an adipogenic program in muscle satellite cells. Such findings could be very important in the general context of muscle development, but also in the specific context of obesity and type 2 diabetes. In these pathologies, skeletal muscle has been observed to have a reduced oxidative enzyme activity, increased glycolytic activity, and increased lipid content. These metabolic characteristics are related to skeletal muscle insulin resistance and are factors potentially related to muscle fiber type [36], particularly for fast MyHC-expressing fibers [31]. To address this important topic, we are now studying the effects of direct electrotransfection of Wnt10b and other Wnt factors in mouse Tibialis Anterior and Soleus muscles on fiber-type composition, metabolism, intramyocellular lipid content and insulin sensitivity.
###end p 75
###begin title 76
Wnt10b and SREBP-1c Are Mutually Exclusive in Muscle
###end title 76
###begin p 77
###xml 86 90 80 84 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Y216</sup>
###xml 149 163 143 157 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0008509-g008">Figures 8a, 8b</xref>
###xml 337 346 328 337 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0008509-g008">Figure 8f</xref>
###xml 595 599 586 590 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008509-GuilletDeniau1">[15]</xref>
###xml 709 713 700 704 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008509-Miyake1">[37]</xref>
###xml 801 805 792 796 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008509-Cusi1">[38]</xref>
###xml 942 946 933 937 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008509-Nadeau1">[39]</xref>
###xml 1056 1064 1047 1055 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0008509-g008">Fig. 8-c</xref>
###xml 1361 1374 1349 1362 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0008509-g008">Figure 8a, 8b</xref>
Wnt10b and BIO activate the Wnt/beta-catenin pathway through inactivation of GSK-3betaY216 both in insulin-sensitive and insulin-resistant myotubes (Figures 8a, 8b), which resulted in nuclear translocation of active beta-catenin, stimulation of myogenic genes transcription (e.g myoD, myogenin) and inhibition of Srebp-1c transcription (Figure 8f). In fact, three putative consensus sequences for sterol regulatory elements (SRE) are present in the Wnt10b promoter, and we have already shown negative regulation by Srebp-1c on the mitochondrial uncoupling protein, UCP3, in contracting myotubes [15]. On the other hand, insulin resistance is accompanied by various degrees of impairment of the PI3K signaling [37], whereas the MAPK pathway does not appear defective in the state of insulin resistance [38]. In skeletal muscle cells, insulin-induced Srebp-1c transcription was shown to be mediated by the MAPK pathway, not by the PI3K pathway [39]. In this case, insulin-stimulated expression of SREBP-1c would remain intact in the insulin-resistant state (Fig. 8-c), which could explain increased lipogenesis and intramyocellular lipid deposition. In contrast, stimulation of the Wnt/beta-catenin pathway would inhibit the MAPK pathway in insulin-sensitive and insulin-resistant myotubes as well, which could explain the down-regulation of Srebp-1c expression (Figure 8a, 8b). Nevertheless, the mechanism involved in the reciprocal regulation of Wnt10b and Srebp-1c remains to be elucidated at the transcriptional level.
###end p 77
###begin title 78
Hypothesis for an interplay between insulin and BIO signaling in contracting myotubes.
###end title 78
###begin p 79
###xml 8 9 8 9 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">a</bold>
###xml 20 21 20 21 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">b</bold>
###xml 98 102 92 96 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Y216</sup>
###xml 287 288 278 279 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">f</bold>
###xml 479 480 470 471 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">c</bold>
###xml 521 525 509 513 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Y216</sup>
###xml 568 572 556 560 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">S241</sup>
###xml 598 602 586 590 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">T308</sup>
###xml 616 620 604 608 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">S473</sup>
###xml 667 671 655 659 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">S588</sup>
###xml 701 702 689 690 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">e</bold>
###xml 778 782 766 770 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">S473</sup>
###xml 798 799 786 787 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">d</bold>
###xml 869 873 853 857 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">S485</sup>
###xml 915 916 899 900 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">e</bold>
Wnt10b (a) and BIO (b) activate the Wnt/beta-catenin pathway through the inactivation of GSK-3betaY216 phosphorylation, which results in the nuclear translocation of active beta-catenin, stimulation of myogenic genes transcription such as myoD, and inhibition of Srebp-1c transcription (f). Insulin-induced Srebp-1c transcription is mediated by the MAPK pathway in muscle cells. BIO inhibits the MAPK pathway, which could explain the down-regulation of Srebp-1c gene expression (c). In parallel, inactivation of GSK-3betaY216 is followed by autophosphorylation of PDK1S241 which phosphorylates Akt1T308 (but not Akt2S473), then the subsequent phosphorylation of AS160S588 induces GLUT4 translocation (e). In contrast, insulin stimulates GLUT4 translocation through the PI3K/Akt2S473/AS160 pathway (d). BIO activates the AMP kinase pathway by phosphorylating AMPK-alpha1S485, which also induces GLUT4 translocation (e). These results strongly suggest that Wnt signaling, in contrast to insulin signaling, increases glucose transport in both insulin-sensitive and insulin-resistant myotubes through the activation of AMPK-alpha1 and Akt2/AS160 pathways.
###end p 79
###begin title 80
Hypothesis for an Interplay between Wnt Signaling and Insulin Sensitivity in Muscle Cells
###end title 80
###begin p 81
###xml 96 100 96 100 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008509-Hara1">[40]</xref>
###xml 141 145 141 145 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008509-Etgen1">[41]</xref>
###xml 194 198 194 198 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008509-Hayashi1">[42]</xref>
###xml 361 365 358 362 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Y216</sup>
###xml 409 413 406 410 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">T308</sup>
###xml 467 471 464 468 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">S588</sup>
###xml 566 570 563 567 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">S241</sup>
###xml 626 630 620 624 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Y216</sup>
###xml 665 674 659 668 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0008509-g008">Figure 8b</xref>
###xml 792 796 779 783 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008509-Meijer1">[30]</xref>
###xml 892 896 871 875 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008509-Zahler1">[43]</xref>
###xml 1139 1143 1114 1118 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">S473</sup>
###xml 1175 1179 1150 1154 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008509-Bouzakri1">[44]</xref>
###xml 1275 1284 1250 1259 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0008509-g008">Figure 8d</xref>
###xml 1361 1365 1332 1336 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">S485</sup>
###xml 1385 1389 1352 1356 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">T172</sup>
###xml 1448 1457 1415 1424 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0008509-g008">Figure 8e</xref>
###xml 1519 1523 1486 1490 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008509-Jensen1">[29]</xref>
###xml 1153 1158 <span type="species:ncbi:9606">human</span>
###xml 1616 1621 <span type="species:ncbi:10090">mouse</span>
Stimuli that induce GLUT4 translocation in skeletal muscle include insulin via the PI3K pathway [40], hypoxia through nitric oxide signaling [41] and contraction/exercise through AMPK signaling [42]. Wnt signaling stimulated glucose transport independent of insulin, but also restored insulin sensitivity in insulin-resistant myotubes. Inactivation of GSK-3betaY216 was followed by the phosphorylation of Akt1T308 by PDK1. Then the subsequent phosphorylation of AS160S588 induced GLUT4 translocation to the plasma membrane. We don't know yet whether BIO induced PDK1S241 autophosphorylation through the inhibition of GSK-3betaY216 or via a pathway not yet defined (Figure 8b). In fact, BIO was reported to be an inhibitor of GSK-3alpha/beta through interactions within the ATP binding pocket [30], but also an inhibitor of PDK1 in silico at concentrations ranging from 10 microM to 30 microM [43]. In our study, BIO 1 microM was an activator of PDK1 autophosphorylation in myotubes that were either sensitive or resistant to insulin. Insulin-induced GLUT4 translocation was reported to occur through a pathway involving IRS1/PI3K/PDK2/Akt2S473/AS160 in human skeletal muscle [44], and our results show that insulin stimulated a similar pathway in insulin-sensitive myotubes (Figure 8d). In addition, BIO activated the AMPK pathway by phosphorylating AMPK-alpha1S485, but not AMPK-alphaT172 both in insulin-sensitive and insulin-resistant myotubes (Figure 8e). These results are in accordance with those of Jensen et al [29] which found that twitch-contraction increased AMPK-alpha1 activity, but not AMPK-alpha2, in mouse skeletal muscle. Altogether our findings demonstrate that Wnt signaling increased glucose transport in both insulin-sensitive and insulin-resistant myotubes through a differential activation of Akt2/AS160 and AMPK-alpha1 pathways. Nevertheless, how BIO could have a permissive effect on insulin action in insulin-resistant myotubes remains to be determined.
###end p 81
###begin p 82
As a switch in the differentiation potential of satellite cells to an adipogenic phenotype could be partly responsible for intramyocellular lipid deposition and insulin resistance in type 2 diabetes, obesity and age-related sarcopenia, organe-selective modulation of the Wnt/beta-catenin pathway could contribute to fight intramuscular fat depots and improve insulin sensitivity in these pathologies. For that purpose, the use of GSK-3beta-specific inhibitors such as BIO-derivatives may have practical applications in endocrine and regenerative medicine. Nevertheless, as uncontroled canonical Wnt signaling is a hallmark of cancer and other degenerative diseases, understanding the ways in which the pathway is regulated in skeletal muscle is of critical importance.
###end p 82
###begin title 83
Materials and Methods
###end title 83
###begin title 84
Ethics Statement
###end title 84
###begin p 85
Animal experiments were conducted in accordance with the Europeen convention STE 123 and the French decree 2001-286.
###end p 85
###begin title 86
Animals and Regeneration Experiments
###end title 86
###begin p 87
###xml 166 170 166 170 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008509-Bassaglia1">[22]</xref>
###xml 126 130 <span type="species:ncbi:10116">rats</span>
Regeneration experiments were conducted on crushed Extensor Digitorum Longus (EDL) muscles of 2 month-old Sprague Dawley male rats according to Bassaglia and Gautron [22]. After 2, 8 or 30 days, regenerated muscles were harvested and immediately frozen in liquid nitrogen.
###end p 87
###begin title 88
Primary Culture of Muscle Satellite Cells and Glucose Uptake
###end title 88
###begin p 89
###xml 90 94 90 94 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008509-GuilletDeniau3">[45]</xref>
###xml 380 381 371 372 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">3</sup>
###xml 444 448 435 439 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008509-GuilletDeniau3">[45]</xref>
###xml 235 240 <span type="species:ncbi:9796">horse</span>
Satellite cells from hind limb muscles were isolated and cultured as previously described [45]. Cells were allowed to differentiate onto growth factor-reduced Matrigeltrade mark-coated flasks (BD-Biosciences) in DMEM medium containing horse serum, then serum was totally removed to induce contraction. Glucose uptake assay was performed in contracting myotubes using 2-deoxy-D-[1-3H]glucose (Amersham Pharmacia Biotech) as previously described [45]. Results are expressed as means+/-SE. Statistical significance was evaluated using ANOVA.
###end p 89
###begin title 90
RNA Isolation and Semi-Quantitative RT-PCR
###end title 90
###begin p 91
###xml 250 276 250 276 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="gene">5&#8242;-GGAGCCATGGATTGCACATT-3&#8242;</named-content>
###xml 288 314 288 314 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="gene">5&#8242;-GCTTCCAGAGAGGAGCCCAG-3&#8242;</named-content>
###xml 333 363 330 360 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="gene">5&#8242;-TCATGAAGTGTGACGTTGACATCC-3&#8242;</named-content>
###xml 375 405 372 402 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="gene">5&#8242;-GTAAAACGCAGCTCAGTAACAGTC-3&#8242;</named-content>
###xml 420 445 417 442 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="gene">5&#8242;GGTACTTGGCGAGAGTGGAG-3&#8242;</named-content>
###xml 457 483 454 480 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="gene">5&#8242;-AGGGCCAGTGTTTCACATTC-3&#8242;</named-content>
###xml 501 531 495 525 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="gene">5&#8242;-CTCAACATGGAATGTCGGGTGTGC-3&#8242;</named-content>
###xml 543 573 537 567 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="gene">5&#8242;-CTGATCTCGTTGTAGGGCGGCAGC-3&#8242;</named-content>
###xml 592 623 582 613 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="gene">5&#8242;-ATGAAGACATTCCATTCACAAGAGC-3&#8242;</named-content>
###xml 635 666 625 656 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="gene">5&#8242;-ATAGTGGAAGCCAGATGCTTTATCC-3&#8242;</named-content>
###xml 197 202 <span type="species:ncbi:10090">mouse</span>
Total RNA was extracted using TRIzol reagent (Invitrogen) according to the supplier's instructions. Gene expression was measured using semi-quantitative RT-PCR. Sense and antisense primers against mouse cDNAs were designed as follows: SREBP-1c sense 5'-GGAGCCATGGATTGCACATT-3'; antisense 5'-GCTTCCAGAGAGGAGCCCAG-3'. beta-actin sense 5'-TCATGAAGTGTGACGTTGACATCC-3'; antisense 5'-GTAAAACGCAGCTCAGTAACAGTC-3'. MYHC-2 sense 5'GGTACTTGGCGAGAGTGGAG-3'; antisense 5'-AGGGCCAGTGTTTCACATTC-3'; PPAR-beta sense 5'-CTCAACATGGAATGTCGGGTGTGC-3'; antisense 5'-CTGATCTCGTTGTAGGGCGGCAGC-3'; PPAR-gamma sense 5'-ATGAAGACATTCCATTCACAAGAGC-3'; antisense 5'-ATAGTGGAAGCCAGATGCTTTATCC-3'. Results were obtained from three to four independent RNA samples from individual experiments, each tested in triplicate.
###end p 91
###begin title 92
Preparation of Protein Extracts and Plasma Membranes
###end title 92
###begin p 93
###xml 257 261 248 252 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008509-GuilletDeniau1">[15]</xref>
Cytoplasmic and nuclear protein extracts were prepared using the NE-PERtrade mark Nuclear and Cytoplasmic Extraction Reagents kit (Pierce) according to the supplier's instructions. Plasma membranes were isolated according to a protocol previously described [15].
###end p 93
###begin title 94
Western Blot Analysis
###end title 94
###begin p 95
Cells were immediately frozen in liquid nitrogen, scraped in ice-cold RIPA buffer containing 1 mM PMSF, 2 microg/ml pepstatin A, 2.5 microg/ml benzamidine, 2 microg/ml leupeptin and 5 microg/ml aprotinin, then lysed for 2 hours at 4degreesC under rotational agitation. Total cell lysates were recovered after centrifugation at 16,000xg for 30 minutes at 4degreesC to discard insoluble material. Proteins (30 microg) were subjected to immunoblot analysis.
###end p 95
###begin title 96
Antibodies
###end title 96
###begin p 97
###xml 262 268 256 262 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Ser473</sup>
###xml 276 282 270 276 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Thr308</sup>
###xml 328 332 319 323 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Ser9</sup>
###xml 347 353 334 340 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Ser485</sup>
###xml 367 373 350 356 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Thr172</sup>
###xml 381 387 364 370 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Ser241</sup>
###xml 646 652 619 625 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Ser588</sup>
###xml 694 700 664 670 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Tyr216</sup>
###xml 65 70 <span type="species:ncbi:9606">human</span>
###xml 203 209 <span type="species:ncbi:9986">Rabbit</span>
###xml 429 435 <span type="species:ncbi:9986">Rabbit</span>
SREBP-1c was detected using a monoclonal antibody raised against human SREBP-1 (NeoMarkers). Polyclonal antibodies against MyoD, GAPDH, Wnt10b, GLUT4 and beta-tubulin were from Santa-Cruz Biotechnology. Rabbit monoclonal antibodies against GSK-3beta, Akt, P-Akt2Ser473, P-Akt1Thr308 and polyclonal antibodies against P-GSK-3betaSer9, P-AMPK-alpha1Ser485, P-AMPK-alphaThr172, P-PDK1Ser241 and Lamine A/C were from Cell Signaling. Rabbit monoclonal antibodies against AMPK-alpha1 and beta-catenin were from Epitomics. Monoclonal antibody against active beta-catenin was from Chemicon, as well as GLUT1 and AS160 antibodies. Antibody against P-AS160Ser588 was from Symansis. Monoclonal P-GSK-3betaTyr216 antibody was from BD-Transduction Laboratories. Monoclonal antibodies against MyHC-Dev, MyHC-2 were purchased from Sigma and anti-myogenin from DAKO. Anti-FAS polyclonal antibody was a gift from Dr Dugail (Paris).
###end p 97
###begin title 98
siRNA Design
###end title 98
###begin p 99
###xml 94 98 94 98 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008509-GuilletDeniau2">[25]</xref>
###xml 45 48 <span type="species:ncbi:10116">rat</span>
###xml 226 231 <span type="species:ncbi:10090">mouse</span>
A target-specific 21-nt siRNA duplex against rat SREBP-1 was designed as previously described [25] and purchased from Dharmacon (Lafayette, CO). Wnt10b siRNA was a pool of 3 target-specific 20-25-nt siRNAs designed to silence mouse Wnt10b gene (Santa-Cruz Biotechnology). Control siRNAs consisted of scrambled sequences that will not lead to the specific degradation of any known cellular mRNA.
###end p 99
###begin title 100
Transfection of Myotubes
###end title 100
###begin p 101
###xml 177 182 <span type="species:ncbi:10090">mouse</span>
Myotubes were cultured in 6-well plates in DMEM without serum, and antibiotics were removed the day before transfection. SiRNA (60 pmoles/well) or pCAGGS plasmid containing the mouse Wnt10b cDNA were transfected using Lipofectamine 2000 (Invitrogen) according to the manufacturer's instructions. Experiments were performed 48 hours later.
###end p 101
###begin title 102
Treatment of Myotubes with 6-Bromo-Indirubin 3'Oxime (BIO)
###end title 102
###begin p 103
###xml 244 246 237 239 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;6</sup>
BIO, a cell-permeable, highly potent, selective, reversible and ATP-competitive specific inhibitor of GSK-3alpha/beta activity, was provided by Drs A. Brivanlou and L. Meijer (The Rockefeller University, New York). Myotubes were treated with 10-6 M BIO for 48 hours, or with Me-BIO, an inactive form, as a control, then 2-deoxyglucose uptake was performed, or total protein lysates and plasma membranes were prepared.
###end p 103
###begin title 104
Intramyocellular Lipid Accumulation
###end title 104
###begin p 105
###xml 102 106 102 106 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008509-Koopman1">[46]</xref>
Intramyocellular lipids were detected in myotubes using Oil Red O staining according to Koopman et al [46]. Nuclei were counterstained with DAPI (Molecular Probes), then fluorescence was observed using a Nikon TS100 fluorescence microscope.
###end p 105
###begin p 106
We thank Dr A. Brivanlou and Dr L. Meijer (The Rockefeller University, New York) for providing 6-Bromoindirubin-3'-oxime (BIO).
###end p 106
###begin title 107
References
###end title 107
###begin article-title 108
Association of the gene encoding wingless-type mammary tumor virus integration-site family member 5B (WNT5B) with type 2 diabetes.
###end article-title 108
###begin article-title 109
Wnt signaling: relevance to beta-cell biology and diabetes.
###end article-title 109
###begin article-title 110
Glucose induces an autocrine activation of the Wnt/beta-catenin pathway in macrophage cell lines.
###end article-title 110
###begin article-title 111
beta-catenin is a target for the ubiquitin-proteasome pathway.
###end article-title 111
###begin article-title 112
Wnt signaling and the activation of myogenesis in mammals.
###end article-title 112
###begin article-title 113
Wnt signaling regulates the function of MyoD and myogenin.
###end article-title 113
###begin article-title 114
The Wnts.
###end article-title 114
###begin article-title 115
Diseases of liporegulation: new perspective on obesity and related disorders.
###end article-title 115
###begin article-title 116
###xml 154 159 <span type="species:ncbi:9606">human</span>
Intramyocellular lipid is associated with resistance to in vivo insulin actions on glucose uptake, antilipolysis, and early insulin signaling pathways in human skeletal muscle.
###end article-title 116
###begin article-title 117
Intramyocellular lipids and insulin resistance.
###end article-title 117
###begin article-title 118
###xml 61 65 <span type="species:ncbi:10116">rats</span>
Insulin selectively increases SREBP-1c mRNA in the livers of rats with streptozotocin-induced diabetes.
###end article-title 118
###begin article-title 119
Sterol regulatory element binding protein-1c is a major mediator of insulin action on the hepatic expression of glucokinase and lipogenesis-related genes [see comments].
###end article-title 119
###begin article-title 120
ADD1/SREBP-1c is required in the activation of hepatic lipogenic gene expression by glucose.
###end article-title 120
###begin article-title 121
###xml 44 49 <span type="species:ncbi:9606">human</span>
Regulation by insulin of gene expression in human skeletal muscle and adipose tissue. Evidence for specific defects in type 2 diabetes.
###end article-title 121
###begin article-title 122
###xml 70 73 <span type="species:ncbi:10116">rat</span>
Sterol regulatory element binding protein-1c expression and action in rat muscles: insulin-like effects on the control of glycolytic and lipogenic enzymes and UCP3 gene expression.
###end article-title 122
###begin article-title 123
Activation of an adipogenic program in adult myoblasts with age.
###end article-title 123
###begin article-title 124
Wnt/beta-catenin signaling in adipogenesis and metabolism.
###end article-title 124
###begin article-title 125
The molecular regulation of myogenesis.
###end article-title 125
###begin article-title 126
Trans-differentiation of myoblasts to adipoblasts: triggering effects of fatty acids and thiazolidinediones.
###end article-title 126
###begin article-title 127
Thiazolidinediones and fatty acids convert myogenic cells into adipose-like cells.
###end article-title 127
###begin article-title 128
High glucose induces adipogenic differentiation of muscle-derived stem cells.
###end article-title 128
###begin article-title 129
###xml 14 17 <span type="species:ncbi:10116">rat</span>
Fast and slow rat muscles degenerate and regenerate differently after whole crush injury.
###end article-title 129
###begin article-title 130
Regulation and localization of tyrosine216 phosphorylation of glycogen synthase kinase-3beta in cellular and animal models of neuronal degeneration.
###end article-title 130
###begin article-title 131
###xml 31 36 <span type="species:ncbi:9606">human</span>
###xml 41 46 <span type="species:ncbi:10090">mouse</span>
Maintenance of pluripotency in human and mouse embryonic stem cells through activation of Wnt signaling by a pharmacological GSK-3-specific inhibitor.
###end article-title 131
###begin article-title 132
###xml 39 42 <span type="species:ncbi:10116">rat</span>
Glucose induces de novo lipogenesis in rat muscle satellite cells through a sterol-regulatory-element-binding-protein-1c-dependent pathway.
###end article-title 132
###begin article-title 133
Mechanism of activation of protein kinase B by insulin and IGF-1.
###end article-title 133
###begin article-title 134
Phosphorylation and regulation of Akt/PKB by the rictor-mTOR complex.
###end article-title 134
###begin article-title 135
AMP-activated protein kinase: ancient energy gauge provides clues to modern understanding of metabolism.
###end article-title 135
###begin article-title 136
###xml 112 117 <span type="species:ncbi:10090">mouse</span>
AMPK alpha1 activation is required for stimulation of glucose uptake by twitch contraction, but not by H2O2, in mouse skeletal muscle.
###end article-title 136
###begin article-title 137
GSK-3-selective inhibitors derived from Tyrian purple indirubins.
###end article-title 137
###begin article-title 138
Involvement of Wnt4 signaling during myogenic proliferation and differentiation of skeletal muscle.
###end article-title 138
###begin article-title 139
Inhibition of adipogenesis by Wnt signaling.
###end article-title 139
###begin article-title 140
Regulation of Wnt signaling during adipogenesis.
###end article-title 140
###begin article-title 141
###xml 123 127 <span type="species:ncbi:10116">rats</span>
Skeletal muscle sterol regulatory element binding protein-1c decreases with food deprivation and increases with feeding in rats.
###end article-title 141
###begin article-title 142
Wnt10b deficiency promotes coexpression of myogenic and adipogenic programs in myoblasts.
###end article-title 142
###begin article-title 143
###xml 131 136 <span type="species:ncbi:9606">women</span>
Skeletal muscle glycolytic and oxidative enzyme capacities are determinants of insulin sensitivity and muscle composition in obese women.
###end article-title 143
###begin article-title 144
Hyperinsulinemia, glucose intolerance, and dyslipidemia induced by acute inhibition of phosphoinositide 3-kinase signaling in the liver.
###end article-title 144
###begin article-title 145
###xml 96 101 <span type="species:ncbi:9606">human</span>
Insulin resistance differentially affects the PI 3-kinase- and MAP kinase-mediated signaling in human muscle.
###end article-title 145
###begin article-title 146
Insulin regulation of sterol regulatory element-binding protein-1 expression in L-6 muscle cells and 3T3 L1 adipocytes.
###end article-title 146
###begin article-title 147
1-Phosphatidylinositol 3-kinase activity is required for insulin-stimulated glucose transport but not for RAS activation in CHO cells.
###end article-title 147
###begin article-title 148
Nitric oxide stimulates skeletal muscle glucose transport through a calcium/contraction- and phosphatidylinositol-3-kinase-independent pathway.
###end article-title 148
###begin article-title 149
Evidence for 5' AMP-activated protein kinase mediation of the effect of muscle contraction on glucose transport.
###end article-title 149
###begin article-title 150
Inverse in silico screening for identification of kinase inhibitor targets.
###end article-title 150
###begin article-title 151
###xml 117 122 <span type="species:ncbi:9606">human</span>
siRNA-based gene silencing reveals specialized roles of IRS-1/Akt2 and IRS-2/Akt1 in glucose and lipid metabolism in human skeletal muscle.
###end article-title 151
###begin article-title 152
###xml 138 141 <span type="species:ncbi:10116">rat</span>
Expression and cellular localization of glucose transporters (GLUT1, GLUT3, GLUT4) during differentiation of myogenic cells isolated from rat foetuses.
###end article-title 152
###begin article-title 153
Optimisation of oil red O staining permits combination with immunofluorescence and automated quantification of lipids.
###end article-title 153
###begin p 154
###xml 0 21 0 21 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Competing Interests: </bold>
Competing Interests: The authors have declared that no competing interests exist.
###end p 154
###begin p 155
###xml 0 9 0 9 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Funding: </bold>
Funding: This work was supported by a grant (number 13491) from the Association Francaise contre les Myopathies (AFM, ), and a subvention from the Institut National de la Sante et de la Recherche Medicale (INSERM). Eleni Christodoulou-Vafeiadou is the recipient of a research fellowship from the "region Ile-de-France". The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.
###end p 155

